跳至主要内容
临床试验/NCT07630753
NCT07630753进行中(未招募)不适用

Effect of Preoperative Pregabalin on Optic Nerve Sheath Diameter as a Surrogate for Intracranial Pressure in Elective Craniotomy Patients.

Benha University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年5月25日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1

研究概览

简要总结

When patients undergo brain tumor removal surgery (craniotomy), the pressure inside the skull may increase, which can lead to brain swelling and slower recovery. Currently, doctors measure this pressure using invasive monitors placed inside the brain, but these are not used for all patients.

This study investigates whether a medication called pregabalin, given before surgery, can help reduce pressure inside the skull. Pregabalin is already approved for treating pain, anxiety, and seizures. The study will measure pressure indirectly using a simple, painless ultrasound of the eye (optic nerve sheath diameter), which is a validated non-invasive method to estimate intracranial pressure.

Participants will be randomly assigned to receive either pregabalin 150 mg or a placebo (inactive pill) on the evening before surgery and again on the morning of surgery. The ultrasound measurement will be taken at four time points: before the first dose, before anesthesia induction, upon arrival to the intensive care unit, and 24 hours after surgery. Researchers will also measure pain levels, medication use, and recovery quality.

The goal is to determine if preoperative pregabalin can safely reduce intracranial pressure and improve recovery in craniotomy patients.

详细描述

This study is a prospective, randomized, double-blind, placebo-controlled trial. It will be conducted in the operating rooms and neurosurgical intensive care unit at the study hospital. The study population consists of adult patients aged eighteen to sixty-five years who are scheduled for elective supratentorial craniotomy to remove a brain tumor.

Participants will be randomly assigned in a one-to-one ratio to receive either pregabalin 150 mg or an identical placebo capsule. The study drug will be administered orally on the evening before surgery and again ninety minutes before anesthesia induction on the day of surgery. Neither the participants nor the treating physicians or outcome assessors will know which group the participant belongs to.

The primary outcome of the study is the optic nerve sheath diameter measured by ultrasound at the pre-induction time point, which is ninety minutes after the second dose of the study drug. An optic nerve sheath diameter greater than 5.5 millimeters is considered indicative of elevated intracranial pressure. Secondary outcomes include optic nerve sheath diameter at baseline, upon intensive care unit arrival, and twenty-four hours after surgery; the incidence of elevated optic nerve sheath diameter at each time point; postoperative pain scores; total opioid consumption in the first twenty-four hours; time to first pain medication request; the incidence of postoperative delirium; quality of recovery scores; preoperative anxiety levels; and any adverse events such as sedation, dizziness, nausea, or vomiting.

The sample size is one hundred participants, with fifty participants in each group. This calculation was based on an expected difference of 0.3 millimeters in optic nerve sheath diameter between groups, a standard deviation of 0.5 millimeters, an alpha level of 0.05, a power of eighty percent, and an anticipated ten percent dropout rate.

Anesthesia will be standardized for all participants using sevoflurane for maintenance. Fentanyl will be used for intraoperative pain control, and the total amount given will be recorded. Optic nerve sheath diameter measurements will be performed using a high-frequency linear ultrasound probe placed gently over the closed eyelid. Three measurements will be taken from each eye, and the average will be calculated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-65 years
  • ASA status: I-III
  • Surgery Elective supratentorial craniotomy for tumor resection (meningioma, glioma, metastasis)
  • Anesthesia: General anesthesia with sevoflurane
  • Consent: Written informed consent obtained

排除标准

  • Known hypersensitivity to pregabalin or gabapentinoids.
  • Pre-existing optic nerve pathology or glaucoma that could cause ONSD measurement interference.
  • Emergency surgery as No preoperative dosing window
  • Preoperative ICP elevation (suspected or confirmed) to avoid Baseline ICP abnormality
  • Severe renal impairment (CrCl < 30 mL/min).
  • Preoperative use of gabapentinoids or benzodiazepines to avoid drug interaction/interference
  • Pregnancy or breastfeeding for Safety
  • Body mass index > 40 kg/m²
  • History of substance abuse
  • Inability to cooperate with ONSD measurement

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samar Rafik Mohamed Amin

Assistant professor of anesthesia and intensive care

Benha University

研究点 (1)

Loading locations...

相似试验